Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain

Brain, Behavior, and Immunity

Volumn 42, Issue , 2014, Pages 169-177

  Allette, Yohance M ^a   Due, Michael R ^a   Wilson, Sarah M ^a   Feldman, Polina ^a   Ripsch, Matthew S ^a   Khanna, Rajesh ^a,b   White, Fletcher A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Pharmacology and Toxicology ^*  (United States)

Author keywords

Alarmin; DAMP; Dorsal root ganglia; DRG; HMGB1; Pain; RAGE; TLR4

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; HIGH MOBILITY GROUP B1 PROTEIN; ISOLECTIN B4; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; CALCIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; MALE; NERVE CELL STIMULATION; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PATHOGENESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SPINAL GANGLION; TIBIAL NERVE; UPREGULATION; ANIMAL; COMPLICATION; DISEASE MODEL; HYPERALGESIA; METABOLISM; NERVE CELL; NEURALGIA; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURY; SPRAGUE DAWLEY RAT;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CALCIUM; DISEASE MODELS, ANIMAL; FEMALE; GANGLIA, SPINAL; HMGB1 PROTEIN; HYPERALGESIA; MALE; NEURALGIA; NEURONS; PERIPHERAL NERVE INJURIES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84907270248     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.06.199     Document Type: Article

References (56)

1. Akirav E.M., Preston-Hurlburt P., Garyu J., Henegariu O., Clynes R., Schmidt A.M., et al. RAGE expression in human T cells: a link between environmental factors and adaptive immune responses. PLoS One 2012, 7:e34698.
2. Andersson U., Tracey K.J. HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 2011, 29:139-162.
3. Antoine D.J., Williams D.P., Kipar A., Laverty H., Park B.K. Diet restriction inhibits apoptosis and HMGB1 oxidation and promotes inflammatory cell recruitment during acetaminophen hepatotoxicity. Mol Med 2010, 16:479-490.
4. Bevan D.E., Martinko A.J., Loram L.C., Stahl J.A., Taylor F.R., Joshee S., et al. Selection, preparation, and evaluation of small- molecule inhibitors of toll-like receptor 4. ACS Med Chem Lett 2010, 1:194-198.
5. Bhangoo S., Ren D., Miller R.J., Henry K.J., Lineswala J., Hamdouchi C., Li B., Monahan P.E., Chan D.M., Ripsch M.S., White F.A. Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain 2007, 3:38.
6. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol 2007, 81:1-5.
7. Bianchi M.E., Falciola L., Ferrari S., Lilley D.M. The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J 1992, 11:1055-1063.
8. Calvo M., Dawes J.M., Bennett D.L. The role of the immune system in the generation of neuropathic pain. Lancet Neurol 2012, 11:629-642.
9. Campana L., Bosurgi L., Bianchi M.E., Manfredi A.A., Rovere-Querini P. Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells. J Leukoc Biol 2009, 86:609-615.
10. Chacur M., Milligan E.D., Gazda L.S., Armstrong C., Wang H., Tracey K.J., et al. A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats. Pain 2001, 94:231-244.
11. Cheng K, Wang X, Zhang S, Yin H. Discovery of Small-Molecule Inhibitors of the TLR1/TLR2 Complex. Angew Chem Int Ed Engl. 2012.
12. Czura C.J., Wang H., Tracey K.J. Dual roles for HMGB1: DNA binding and cytokine. J Endotoxin Res 2001, 7:315-321.
13. Diogenes A, Ferraz CC, Akopian AN, Henry MA, Hargreaves KM. LPS Sensitizes TRPV1 via Activation of TLR4 in Trigeminal Sensory Neurons. J Dent Res. 2011;Jun;90(6):759-64.
14. Due M.R., Piekarz A.D., Wilson N., Feldman P., Ripsch M.S., Chavez S., et al. Neuroexcitatory effects of morphine-3-glucuronide are dependent on Toll-like receptor 4 signaling. J Neuroinflammation 2012, 9:200.
15. Dumitriu I.E., Baruah P., Manfredi A.A., Bianchi M.E., Rovere-Querini P. HMGB1: guiding immunity from within. Trends Immunol 2005, 26:381-387.
16. Fages C., Nolo R., Huttunen H.J., Eskelinen E., Rauvala H. Regulation of cell migration by amphoterin. J Cell Sci 2000, 113(Pt 4):611-620.
17. Feldman P., Due M.R., Ripsch M.S., Khanna R., White F.A. The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain. J Neuroinflammation 2012, 9:180.
18. Giese K., Cox J., Grosschedl R. The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assembly of functional nucleoprotein structures. Cell 1992, 69:185-195.
19. Guo J, Hsieh C, Wu Z, DiGiammarino EL, Luo F, Fox GB, et al. Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof. In: Office USPaT, editor. United States: Abbott Laboratories, Abbott Park, IL Abbott GMbH & Co. KG, Wiesbaden-Delkenheim, DE; 2012.
20. Hoppe G., Talcott K.E., Bhattacharya S.K., Crabb J.W., Sears J.E. Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res 2006, 312:3526-3538.
21. Hori O., Brett J., Slattery T., Cao R., Zhang J., Chen J.X., et al. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system. J Biol Chem 1995, 270:25752-25761.
22. Hreggvidsdottir H.S., Lundberg A.M., Aveberger A.C., Klevenvall L., Andersson U., Harris H.E. High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor. Mol Med 2012, 18:224-230.
23. Hua X.Y., Chen P., Fox A., Myers R.R. Involvement of cytokines in lipopolysaccharide-induced facilitation of CGRP release from capsaicin-sensitive nerves in the trachea: studies with interleukin-1beta and tumor necrosis factor-alpha. J Neurosci 1996, 16:4742-4748.
24. Huttunen H.J., Fages C., Kuja-Panula J., Ridley A.J., Rauvala H. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 2002, 62:4805-4811.
25. Iori V., Maroso M., Rizzi M., Iyer A.M., Vertemara R., Carli M., et al. Receptor for Advanced Glycation Endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures. Neurobiol Dis 2013, 58:102-114.
26. Karatas H., Erdener S.E., Gursoy-Ozdemir Y., Lule S., Eren-Kocak E., Sen Z.D., et al. Spreading depression triggers headache by activating neuronal Panx1 channels. Science 2013, 339:1092-1095.
27. Kazama H., Ricci J.E., Herndon J.M., Hoppe G., Green D.R., Ferguson T.A. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008, 29:21-32.
28. Ma C., LaMotte R.H. Enhanced excitability of dissociated primary sensory neurons after chronic compression of the dorsal root ganglion in the rat. Pain 2005, 113:106-112.
29. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nat Med 2010, 16:413-419.
30. Merenmies J., Pihlaskari R., Laitinen J., Wartiovaara J., Rauvala H. 30-kDa heparin-binding protein of brain (amphoterin) involved in neurite outgrowth. Amino acid sequence and localization in the filopodia of the advancing plasma membrane. J Biol Chem 1991, 266:16722-16729.
31. Nakamura Y., Morioka N., Abe H., Zhang F.F., Hisaoka-Nakashima K., Liu K., et al. Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonal antibody to high mobility group box-1. PLoS One 2013, 8:e73640.
32. Ochoa-Cortes F., Ramos-Lomas T., Miranda-Morales M., Spreadbury I., Ibeakanma C., Barajas-Lopez C., et al. Bacterial cell products signal to mouse colonic nociceptive dorsal root ganglia neurons. Am J Physiol Gastrointest Liver Physiol 2010, 299:723-732.
33. O'Connor KA, Hansen MK, Rachal Pugh C, Deak MM, Biedenkapp JC, Milligan ED, et al. Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine. 2003;24:254-65.
34. Otoshi K, Kikuchi S, Kato K, Sekiguchi M, Konno S, et et al. Anti-HMGB1 neutralization antibody improves pain-related behavior induced by application of autologous nucleus pulposus onto nerve roots in rats. Spine (Phila Pa 1976). 2011;36:E692-8.
35. Parkkinen J., Raulo E., Merenmies J., Nolo R., Kajander E.O., Baumann M., et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem 1993, 268:19726-19738.
36. Qiu J., Xu J., Zheng Y., Wei Y., Zhu X., Lo E.H., et al. High-mobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke 2010, 41:2077-2082.
37. Rauvala H., Pihlaskari R. Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J Biol Chem 1987, 262:16625-16635.
38. Rong L.L., Trojaborg W., Qu W., Kostov K., Yan S.D., Gooch C., et al. Antagonism of RAGE suppresses peripheral nerve regeneration. FASEB J 2004, 18:1812-1817.
39. Rong L.L., Yan S.F., Wendt T., Hans D., Pachydaki S., Bucciarelli L.G., et al. RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways. FASEB J 2004, 18:1818-1825.
40. Rouhiainen A., Kuja-Panula J., Wilkman E., Pakkanen J., Stenfors J., Tuominen R.K., et al. Regulation of monocyte migration by amphoterin (HMGB1). Blood 2004, 104:1174-1182.
41. Rouhiainen A., Kuja-Panula J., Tumova S., Rauvala H. RAGE-Mediated Cell Signaling. Methods Mol Biol 2013, 963:239-263.
42. Sahu D., Debnath P., Takayama Y., Iwahara J. Redox properties of the A-domain of the HMGB1 protein. FEBS Lett 2008, 582:3973-3978.
43. Sha Y., Zmijewski J., Xu Z., Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 2008, 180:2531-2537.
44. Shibasaki M., Sasaki M., Miura M., Mizukoshi K., Ueno H., Hashimoto S., et al. Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury. Pain 2010, 149:514-521.
45. Strakhova MI, Desiree-Brederson J. Antibodies to receptor of advanced glycation end products (RAGE) and uses thereof. In: Office USPaT, editor. United States: Abbvie Inc., North Chicago, IL 2013.
46. Ulloa L., Tracey K.J. The "cytokine profile": a code for sepsis. Trends Mol Med 2005, 11:56-63.
47. Venereau E., Schiraldi M., Uguccioni M., Bianchi M.E. HMGB1 and leukocyte migration during trauma and sterile inflammation. Mol Immunol 2013, 55(1):76-82. 10.1016/j.molimm.2012.10.037.
48. Vezzoli M., Castellani P., Campana L., Corna G., Bosurgi L., Manfredi A.A., et al. Redox remodeling: a candidate regulator of HMGB1 function in injured skeletal muscle. Ann N Y Acad Sci 2010, 1209:83-90.
49. Vezzoli M., Castellani P., Corna G., Castiglioni A., Bosurgi L., Monno A., et al. High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle. Antioxid Redox Signal 2011, 15:2161-2174.
50. White F.A., Bhangoo S.K., Miller R.J. Chemokines: integrators of pain and inflammation. Nat Rev Drug Discov 2005, 4:834-844.
51. Yang H., Hreggvidsdottir H.S., Palmblad K., Wang H., Ochani M., Li J., et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A 2010, 107:11942-11947.
52. Yang Q.W., Lu F.L., Zhou Y., Wang L., Zhong Q., Lin S., et al. HMBG1 mediates ischemia-reperfusion injury by TRIF-adaptor independent Toll-like receptor 4 signaling. J Cereb Blood Flow Metab 2011, 31:593-605.
53. Yang H., Lundback P., Ottosson L., Erlandsson-Harris H., Venereau E., Bianchi M.E., et al. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med 2012, 18:250-259.
54. Zandarashvili L., Sahu D., Lee K., Lee Y.S., Singh P., Rajarathnam K., et al. Real-time kinetics of high-mobility group box 1 (HMGB1) oxidation in extracellular fluids studied by in situ protein NMR spectroscopy. J Biol Chem 2013, 288:11621-11627.
55. Zhang J.M., Song X.J., LaMotte R.H. Enhanced excitability of sensory neurons in rats with cutaneous hyperalgesia produced by chronic compression of the dorsal root ganglion. J Neurophysiol 1999, 82:3359-3366.
56. Zhang J., Takahashi H.K., Liu K., Wake H., Liu R., Maruo T., et al. Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 2011, 42:1420-1428.